These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3108293)

  • 1. Current uses of phlebotomy therapy.
    Weintraub LR
    Hosp Pract (Off Ed); 1987 Jun; 22(6):251-4, 256. PubMed ID: 3108293
    [No Abstract]   [Full Text] [Related]  

  • 2. The efficiency of therapeutic erythrocytapheresis compared to phlebotomy in relation to blood volume and delta-hematocrit: an evaluation in hereditary hemochromatosis polycythemia vera and secondary erythrocytosis.
    Evers D; Kerkhoffs JL; Van Egmond L; Wijermans PW
    Transfus Apher Sci; 2013 Apr; 48(2):187. PubMed ID: 23809828
    [No Abstract]   [Full Text] [Related]  

  • 3. The efficiency of therapeutic erythrocytapheresis compared to phlebotomy: a mathematical tool for predicting response in hereditary hemochromatosis, polycythemia vera, and secondary erythrocytosis.
    Evers D; Kerkhoffs JL; Van Egmond L; Schipperus MR; Wijermans PW
    J Clin Apher; 2014 Jun; 29(3):133-8. PubMed ID: 24130064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do I…perform therapeutic phlebotomy?
    Peedin AR; Karp JK
    Transfusion; 2021 Mar; 61(3):673-677. PubMed ID: 33580971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Who needs a therapeutic phlebotomy?
    Antle EA
    Clin J Oncol Nurs; 2010 Dec; 14(6):694-6. PubMed ID: 21112847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current applications of therapeutic phlebotomy.
    Assi TB; Baz E
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s75-83. PubMed ID: 24120605
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic phlebotomy: a review of diagnoses and treatment considerations.
    Cook LS
    J Infus Nurs; 2010; 33(2):81-8. PubMed ID: 20228645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of hemochromatosis and porphyria].
    Strohmeyer G
    Med Welt; 1974 Nov; 25(46):1911-5. PubMed ID: 4456136
    [No Abstract]   [Full Text] [Related]  

  • 9. [Myelofibrosis in polycythemia vera following 15 years of phlebotomy].
    Yonemitsu H; Kondo H; Okuda K; Endo N; Yamaguchi K
    Rinsho Ketsueki; 1983 Aug; 24(8):1092-7. PubMed ID: 6645077
    [No Abstract]   [Full Text] [Related]  

  • 10. Principia of cancer therapy. IV. Induction of hemoconcentration for phlebotomy in polycythemia vera.
    Okuyama S; Mishina H; Ito Y; Matsuzawa T
    Sci Rep Res Inst Tohoku Univ Med; 1983 Dec; 30(1-4):29-30. PubMed ID: 6678498
    [No Abstract]   [Full Text] [Related]  

  • 11. [3 cases of porphyria cutanea tarda--change of urinary porphyrin excretion patterns after phlebotomy].
    Murayama F; Ohgami T; Honda T; Rikimaru M; Hirowatari T; Nonaka S; Yoshida H
    Nihon Hifuka Gakkai Zasshi; 1983 Aug; 93(9):909-15. PubMed ID: 6663799
    [No Abstract]   [Full Text] [Related]  

  • 12. Polycythemia vera, diagnosis and treatment.
    Conley CL
    Hosp Pract (Off Ed); 1987 Mar; 22(3):181-5, 189-200, 205-10. PubMed ID: 3102512
    [No Abstract]   [Full Text] [Related]  

  • 13. [Letter: Therapy of hemochromatosis].
    Kautzsch E
    Med Klin; 1975 Jan; 70(3-2):114. PubMed ID: 1128429
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute myeloblastic leukemia with polycythemia vera. Treated with busulfan and phlebotomy.
    Dittmar K
    N Y State J Med; 1979 Apr; 79(5):758-61. PubMed ID: 286175
    [No Abstract]   [Full Text] [Related]  

  • 15. Hearing improvement induced by phlebotomy in polycythemia.
    Davis EC; Nilo ER
    Laryngoscope; 1965 Dec; 75(12):1847-52. PubMed ID: 5854616
    [No Abstract]   [Full Text] [Related]  

  • 16. [Polycythemia vera, clinical aspects and disease course].
    Heilmann E; Köhler T
    Fortschr Med; 1978 May; 96(18):941-6. PubMed ID: 648997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five cases of porphyria cutanea tarda with mild cutaneous changes: evaluation of the efficacy of phlebotomy by the pattern analysis of urinary porphyrins.
    Nonaka S; Ohgami T; Murayama F; Yamashita K; Yoshida H
    J Dermatol; 1986 Jun; 13(3):196-202. PubMed ID: 3537046
    [No Abstract]   [Full Text] [Related]  

  • 18. Iron out the details of therapeutic phlebotomy.
    Parker DM; Deel PC; Arner SS
    Nursing; 2004 Feb; 34(2):46-7. PubMed ID: 14758329
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of primary siderochromatosis and siderosis: experimental and clinical study].
    Bianco G; Gallo E; Ramello A; Ricco G; Matone S
    Minerva Med; 1969 Dec; 60(97):4881-90. PubMed ID: 5357552
    [No Abstract]   [Full Text] [Related]  

  • 20. Polycythemia vera with uncommon presentations.
    Dincer AP; Subramanian S; Goksel M
    Clin Adv Hematol Oncol; 2003 Nov; 1(11):665-6; discussion 667. PubMed ID: 16258466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.